Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
*Purpose: To evaluate the feasibility of allotransplantation of a ligated arteriovenous fistula
*Methods: We report the first case of allotransplantation of a mature working arterialized cephalic vein for the creation of a femoro-femoral arteriovenous fistula in a patient with multiple vascular access failures. The donor arteriovenous fistula was ligated to avoid right ventricular dysfunction. Latero-terminal arterial and venous anastomosis was performed after the creation of a subcutaneous tunnel for the vascular allograft. The patient received Tacrolimus and Prednisone for 6 weeks. The patient has been on Rivaroxaban since the surgery.
*Results: The AV fistula was utilized 15 days after the vascular allograft transplantation. Doppler US 6 months after the surgery demonstrates a patent vascular allograft with no evidence of thrombosis in any segment and with a flow of 400-450ml/min. The recipient patient receives hemodialysis 3 times per week without any signs of dysfunction
*Conclusions: The result from this case demonstrates the feasibility of arteriovenous fistula transplantation as a novel technique that allows the rapid use and potentially longer durability of the vascular access.
To cite this abstract in AMA style:Jaramillo-Gante MA, Acosta-Hernandez CE, Castro-Casillas PR, Linares-Cervantes IJ. Allotransplantation of Ligated Arteriovenous Fistula as a Novel Strategy for Patients with Multiple Vascular Access Failures [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/allotransplantation-of-ligated-arteriovenous-fistula-as-a-novel-strategy-for-patients-with-multiple-vascular-access-failures/. Accessed September 16, 2021.
« Back to 2020 American Transplant Congress